August 4–6, 2026 | Las Vegas
As one of the world's most influential AI industry events, Ai4 2026 (The Global Artificial Intelligence Conference) will take place from August 4 to 6, 2026, at The Venetian in Las Vegas, USA. The conference gathers global AI pioneers, industry leaders, and leading scholars to discuss the real-world application and future trajectory of AI technologies across various industries.
Dr. Alex Zhavoronkov , Founder and CEO of Insilico Medicine, will attend the conference and deliver two high-profile sessions—a panel discussion alongside top industry experts on "AI's Race to Reinvent Medicine" , and a solo keynote address exploring "How to Address Diseases and Aging Simultaneously Using Frontier AI" .
Panel Discussion
Topic: AI's Race to Reinvent Medicine
Time: Tuesday, August 4, 2026 | 8:30 AM – 8:59 AM (Local Time)
Location: Hall A (Level 2, The Venetian Expo Center)
Centering on the core topic of "AI's Race to Reinvent Medicine" , Dr. Alex Zhavoronkov will join top industry experts on stage. Drawing from Insilico Medicine's real-world practices in AI-driven drug discovery, the panel will systematically analyze the latest breakthroughs across the entire drug development chain, highlight key industry inflection points, and discuss the evolution of the global competitive landscape in the next phase.
Solo Keynote
Topic: Cracking the Code of Life with AI: Using Frontier AI to Develop Therapies Addressing Diseases and Aging at the Same Time
Time: Wednesday, August 5, 2026 | 2:50 PM – 3:10 PM (Local Time)
Location: Palazzo Ballroom M
As one of the most forward-looking sessions at Ai4 2026, Dr. Alex Zhavoronkov will provide a deep dive into Insilico Medicine's differentiated strategy for breakthrough innovation. He will reveal how the company leverages its end-to-end Pharma.AI platform, MMAI Gym specialized trainers, and fully automated robotics laboratory to deeply integrate frontier AI models with automated biological capabilities—unlocking complex targets long considered "undruggable." By reshaping the fundamental drug discovery paradigm, Insilico Medicine is overcoming high industry barrier to entry and exploring the simultaneous development of "dual-purpose therapies" that treat diseases and delay aging at the same time, targeting identical target systems.
About Ai4
Ai4 is a leading global AI industry conference dedicated to bringing together AI technology leaders, researchers, enterprise decision-makers, and innovators to advance the real-world application of AI across industries. Attracting thousands of attendees each year, the conference has become a premier platform for gaining insights into global AI trends, connecting with top-tier resources, and building deep collaborations.
Learn more: https://ai4.io